183 related articles for article (PubMed ID: 32053632)
1. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H
PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632
[TBL] [Abstract][Full Text] [Related]
2. Treating Anthrax-Induced Meningitis in Rabbits.
Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Brosh T; Kobiler D; Weiss S; Levy H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661872
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
[No Abstract] [Full Text] [Related]
5. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
[TBL] [Abstract][Full Text] [Related]
6. Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
Bradley JS; Bulitta JB; Cook R; Yu PA; Iwamoto C; Hesse EM; Chaney D; Yu Y; Kennedy JL; Sue D; Karchmer AW; Bower WA; Hendricks K
Clin Infect Dis; 2024 Jun; 78(6):1451-1457. PubMed ID: 38412060
[TBL] [Abstract][Full Text] [Related]
7. Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
Hejnar P; Kolár M; Chmela Z
Folia Microbiol (Praha); 2004; 49(1):71-4. PubMed ID: 15114869
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
Blahová J; Hupková M; Krcméry V
Cas Lek Cesk; 1995 Sep; 134(17):558-61. PubMed ID: 7553760
[TBL] [Abstract][Full Text] [Related]
9. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Louie A; VanScoy BD; Brown DL; Kulawy RW; Heine HS; Drusano GL
Antimicrob Agents Chemother; 2012 Mar; 56(3):1229-39. PubMed ID: 22155821
[TBL] [Abstract][Full Text] [Related]
10. Management of anthrax meningitis.
Sejvar JJ; Tenover FC; Stephens DS
Lancet Infect Dis; 2005 May; 5(5):287-95. PubMed ID: 15854884
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D
J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Zhang D; Wang Y; Lu J; Pang Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Louie A; Vanscoy BD; Heine HS; Liu W; Abshire T; Holman K; Kulawy R; Brown DL; Drusano GL
Antimicrob Agents Chemother; 2012 Jan; 56(1):513-7. PubMed ID: 22064542
[TBL] [Abstract][Full Text] [Related]
16. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics cure anthrax in animal models.
Weiss S; Kobiler D; Levy H; Pass A; Ophir Y; Rothschild N; Tal A; Schlomovitz J; Altboum Z
Antimicrob Agents Chemother; 2011 Apr; 55(4):1533-42. PubMed ID: 21263056
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Bacillus anthracis in an endemic area.
Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M
Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Amoxicillin and Amoxicillin-Clavulanate (Augmentin) for Antimicrobial Postexposure Prophylaxis Following Bacillus anthracis Inhalational Exposure in Cynomolgus Macaques.
Slay RM; Hatch GJ; Hewitt JA
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S402-S410. PubMed ID: 36251552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
